| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.077 | 0.2 |